Last updated: April 22, 2024
Sponsor: SCF Pharma
Overall Status: Active - Recruiting
Phase
N/A
Condition
Rash
Allergy
Allergies & Asthma
Treatment
Omega-3 monoglyceride based topical Serum and cream of formulation B (rich)
Omega-3 monoglyceride based topical Serum and cream of formulation A (light)
Omega-3 monoglyceride based topical treatment
Clinical Study ID
NCT06155513
COS-PBP-02
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Participant aged of at least 18 years old.
- Participant diagnosed with eczema who did not use corticosteroids in the 14 days priorto study day 1;
- Available for the entire duration of the study and willing to participate based on theinformation provided in the ICF duly read and signed by the latter.
- Participant without intellectual problems likely to limit the validity of consent toparticipate in the study and compliance with protocol requirements, having the abilityto cooperate adequately, understand and observe the instructions of research staff.
Exclusion
Exclusion Criteria:
- None
Study Design
Total Participants: 16
Treatment Group(s): 3
Primary Treatment: Omega-3 monoglyceride based topical Serum and cream of formulation B (rich)
Phase:
Study Start date:
December 20, 2023
Estimated Completion Date:
May 01, 2025
Study Description
Connect with a study center
SCF Pharma
Rimouski, Quebec G0K 1P0
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.